Sunday, March 22, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026
    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
  • Surveys

    Surveys

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026
    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    Perceptions of Viral Wellness Practices on Social Media: A Likert-Scale Survey for Informed Readers

    March 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

Indian State Medical Board Members Discuss Physician Discipline

The conversation was surprisingly nuanced

Jay K Joshi by Jay K Joshi
May 13, 2024
in Politics & Law
0
When Indian State Medical Board Members Discuss Physician Discipline

Memento Media

The American Association of Physicians of Indian Origin and the Association of Telugu Medical Graduates in USA hosted a videoconference that gathered many of the Indian state medical board members.

It was a who’s who of the most successful Indian physicians throughout the country: those who rose to eminence in their state’s medical profession and now regulate the practice of medicine within its boundaries.

The presentation was an informal roundtable discussion where various board members provided insights on topics ranging from board presentations to disciplinary measures.

The conversation was surprisingly nuanced and offered a rare glimpse into the inner workings of medical licensing boards. Most would have expected a conversation rife with generic platitudes. And to be sure, there were a fair amount of generalities evoked and disseminated.

“be nice to your patients and they’ll be less likely to file complaints”

“make sure you properly document everything”

But beneath this veneer lies the heart of the matter and likely why such a presentation was orchestrated in the first place: what makes the Indian physician unique so as to warrant an entire conversation discussing medical licensing board matters?

At first blush, it might appear that the sheer number of Indian physicians has to be taken into consideration in order to answer this question. Indians constitute 1.35 percent of the American population, but make up at least 8.5 percent of the physicians practicing in America. Moreover, Indians are the largest number of International Medical Graduates (IMGs) in this country.

But the overrepresentation of Indian physicians isn’t the issue. It’s the uniqueness of the Indian physician that matters. Throughout the presentation, Indian board members noted specific attributes of Indian physicians that placed them at higher risk of disciplinary actions and board specific sanctions.

“Indian physicians are more entrepreneurial”

“They are more likely to own a medical practice”

“They are more likely to work as an independent practitioner”

These are assumptions most in medicine assume to be true but there’s no data available – at least not publicly – to verify this. But for many Indian physicians, there’s an undercurrent of paranoia. Many believe that they’re greater targets for regulators and overly ambitious prosecutors and attorney generals.

Whatever scant data available is largely inconclusive. There’s no study or body of data to verify this. It’s mere speculation.

But speculative thinking is a funny thing. It’s often the suggestion that proves more powerful than any fact or line of logic. Just look at how rapidly healthcare misinformation and disinformation spreads throughout the internet. Facts walk. Speculation sprints.

And the entire presentation – truly the entire undertone among most, if not all board members, was this: Indian physicians tend to practice medicine in a way that places them at higher risk relative to other physicians. And, as is the case with speculative thinking, all that’s needed is one match to ignite the flame of faith. It came as an innocuous statement close to the end of the presentation.

“Indian physicians are often overconfident”

That statement was uttered by one of the board members. It might as well have encapsulated the entire subtext of the presentation.

Remember, healthcare is a regulated market. In such markets, the regulations define market behavior. Every state has a medical board that oversees the practice of medicine and warrants disciplinary actions when deemed appropriate. This process is fundamentally legal and subjective in nature. There are no clinical studies or established standards of care to guide what happens. Sure, something clinical might be referenced, but ultimately you have a body of individuals making subjective appraisals of individual cases and specific behaviors.

In such a scenario, words matter. And the words uttered during the presentation demonstrate a coherent belief across multiple state board members that Indian physicians are viewed as unique among the physician community: And not in a good way. Remember, the words spoken reflect the thoughts held. Indian physicians are overconfident. They take risks. Sometimes those risks need to be regulated. Indian physicians are unique like that – whether right or wrong, that’s the perception.

This perceived uniqueness puts Indian physicians at greater risk. This much was consistently insinuated and at times openly acknowledged and discussed. For Indian physicians, leery of believing that they would be at greater risk simply for the way they practice medicine, this presentation was a wake-up call.

You are at greater risk of regulatory sanctions because of how you are perceived. The board members have spoken.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Joshi is the founding editor of Daily Remedy.

Comments 0

  1. Zahid Imran says:
    2 years ago

    Very strange. Until now the explanation for the low rate of lawsuits against Indian origin doctors was “they are over cautious/do not take risky cases etc). Such a study was published in India Abroad in late 80’s. Now we are targeted because we are “overconfident”. Most importantly no distinction is made between the discrepancy of still low malpractice cases but more sent to jail. Nut shell – you are Indian. Period. Full Stop. Those who served on medical boards in the US or in India are his master’s voice in general.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

This episode explores deceptive pricing strategies in the GLP-1 medication market, highlighting how healthcare consumerism influences patient decisions and how to recognize and protect against misleading practices.

 key  topics

Deceptive pricing strategies in healthcare
The role of brand perception and pricing manipulation
The concept of drip pricing and hidden costs
The rise of healthcare consumerism and patient agency
Strategies for patients to identify and avoid deceptive practices

Chapters

00:00 The Evolution of the GLP-1 Telemedicine Market
01:12 How Pricing Is Obscured and Perceived Discounts Are Created
02:11 TrumpRx: Coupon Aggregator or Discount Store?
03:12 Why Price Deception Thrives in Healthcare
04:12 The Membership Fee Illusion and Hidden Costs
05:10 Brand Recognition and Drip Pricing Strategies
06:17 The Impact of Brand and Anchor Pricing on Perceived Value
07:16 The Role of Price Drip Strategies in Healthcare Pricing
08:15 The Rise of Healthcare Consumerism and Patient Agency
09:14 How to Protect Yourself from Deceptive Pricing Practices
10:09 Conclusion: Empowering Patients in a Complex Pricing Landscape
Unmasking Deceptive Pricing in Healthcare: What Patients Need to Know
YouTube Video zZgo1nLZVrY
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

by Daily Remedy
March 1, 2026
0

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns

    0 shares
    Share 0 Tweet 0
  • A Call to Action for Pain Patients and Advocates

    1 shares
    Share 0 Tweet 0
  • Healthcare’s Logistics Push

    0 shares
    Share 0 Tweet 0
  • Retatrutide and the Acceleration of Metabolic Medicine

    0 shares
    Share 0 Tweet 0
  • Practicing Medicine Under Consumer Scrutiny

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy